Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Støyten

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cancers|March 10, 2022
Expression of miR-24-1-5p in Tumor Tissue Influences Prostate Cancer Recurrence: The PROCA-<i>life</i> StudyEinar Stikbakke, Tom Wilsgaard, Hege Sagstuen Haugnes, et al.
Clinical Genitourinary Cancer|February 13, 2026
Cardiac Function and Prostate Cancer Risk and Prognosis: The PROCA-Life StudyMartin Støyten, Tore Knutsen, Inger Thune, et al.
Acta Oncologica (Stockholm, Sweden)|April 9, 2024
Excess weight, weight gain, and prostate cancer risk and prognosis: the PROCA-life studyMartin Støyten, Tore Knutsen, Einar Stikbakke, et al.
Cancer Medicine|December 23, 2021
Systolic and diastolic blood pressure, prostate cancer risk, treatment, and survival. The PROCA-life studyEinar Stikbakke, Henrik Schirmer, Tore Knutsen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cancers|March 10, 2022
Expression of miR-24-1-5p in Tumor Tissue Influences Prostate Cancer Recurrence: The PROCA-<i>life</i> StudyEinar Stikbakke, Tom Wilsgaard, Hege Sagstuen Haugnes, et al.
Clinical Genitourinary Cancer|February 13, 2026
Cardiac Function and Prostate Cancer Risk and Prognosis: The PROCA-Life StudyMartin Støyten, Tore Knutsen, Inger Thune, et al.
Acta Oncologica (Stockholm, Sweden)|April 9, 2024
Excess weight, weight gain, and prostate cancer risk and prognosis: the PROCA-life studyMartin Støyten, Tore Knutsen, Einar Stikbakke, et al.
Cancer Medicine|December 23, 2021
Systolic and diastolic blood pressure, prostate cancer risk, treatment, and survival. The PROCA-life studyEinar Stikbakke, Henrik Schirmer, Tore Knutsen, et al.
Pageof 1